About LeadOss
International Patent Design and R&D Cooperation
LeadOss is a newly born independent brand in the field of dental implantology equipped with international cutting-edge manufacturing equipment and testing instruments. We are focusing on the R&D and manufacturing of dental implant systems with world’s leading standards.
Business Philosophy
Improve the quality of life of patients with world-class high-level technology
Corporate Vision
To be a trusted provider of digital dental integration services.
Core Values
Innovative research and development, quality assurance, customer trust, benefiting the public.
Trailer
Company History
2015
2016
2017
2018
2019
2020
2021
2022
2015
June, company registered and established.
November, manufacturing site completed.
2016
May, Start preparation for product registration
November, obtained medical equipment business license for Class II and Class III
2017
Held a clinical kick-off meeting in May
October, Medical Device Registration Certificate for Class II obtained
December, Medical Device Registration Certificate for Class I obtained
December, clinical trials started
2018
June, CE and ISO13485 System Certification obtained
2019
February, all clinical trials completed
February, exhibited in AEEDC Dubai 2019
April, awarded as “Yuhang District Science and Technology Innovation Enterprise”
September, complete A round financing
November, awarded as “Yuhang District R&D Center”
2020
Awarded Zhejiang Science and Technology Small and Medium-sized Enterprise in January
February, completed all clinical follow-ups
September, awarded as “Hangzhou High-tech Enterprise Research and Development Center”
October, FDA approved
2021
July, First appearance in the 12th National Conference On Oral Implant. And successfully held the clinical report and academic exchange meeting of Lido dental implants.
2022
January,NMPA certificate of Tissue Level Dental Implant System and accessories(Class III) obtained
March, Dental South China 2022
Certifications and Patents
China Patent
ISO13485
CE
Korea Patent
FDA